Pages that link to "Item:Q70258"
From MaRDI portal
The following pages link to Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer (Q70258):
Displayed 12 items.
- escalation (Q133814) (← links)
- Optimal Bayesian-feasible dose escalation for cancer phase I trials (Q1265963) (← links)
- Operating characteristics of the standard phase I clinical trial design. (Q1285808) (← links)
- trialr (Q1350867) (← links)
- Using a one-parameter model to sequentially estimate the root of a regression function. (Q1583204) (← links)
- Sequential method of estimating the LD<sub>50</sub> using a modified up-and-down rule (Q4298667) (← links)
- Designs foe phase i cancer clinical trials with differentiation of graded toxicity (Q4548226) (← links)
- A Curve‐Free Method for Phase I Clinical Trials (Q4667490) (← links)
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (Q4670477) (← links)
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210) (← links)
- SEQUENTIAL METHODS IN CLINICAL TRIALS* (Q4804482) (← links)
- Retrospective Analysis of Sequential Dose‐Finding Designs (Q5717156) (← links)